ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.300
-0.060 (-4.41%)
Sep 8, 2026, 4:00 PM EDT - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $165.97 million as of September 8, 2026. Its market cap has decreased by -58.33% in one year.
Market Cap
165.97M
Enterprise Value
385.05M
1-Year Change
-58.33%
Ranking
Category
Stock Price
$1.30
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $165.97M, a decrease of -91.87%. That is a compound annual growth rate of -32.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 165.97M | -62.05% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 278.50M |
| Akebia Therapeutics | 270.10M |
| Cardiol Therapeutics | 257.54M |
| Aurora Cannabis | 255.50M |
| SIGA Technologies | 236.39M |
| Journey Medical | 221.84M |
| Organogenesis Holdings | 220.03M |
| Lifecore Biomedical | 166.55M |